You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

NIS793

Showing 1 - 22 of 22
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Pancreas Cancer, Metastatic Pancreatic Cancer, Metastatic Pancreatic Adenocarcinoma Trial in Boston (drug, radiation, procedure)

Recruiting
  • Pancreas Cancer
  • +2 more
  • Boston, Massachusetts
    Massachusetts General Hospital Cancer Center
Aug 19, 2022

Pancreatic Cancer, Resectable Pancreatic Cancer, Borderline Resectable Pancreatic Adenocarcinoma Trial in Boston (drug,

Not yet recruiting
  • Pancreatic Cancer
  • +3 more
  • Boston, Massachusetts
  • +1 more
Sep 16, 2022

Breast Cancer, Lung Cancer, Hepatocellular Cancer Trial in Worldwide (NIS793, PDR001)

Completed
  • Breast Cancer
  • +5 more
  • Nashville, Tennessee
  • +11 more
Jan 28, 2022

MDS Trial in Worldwide (MBG453, NIS793, canakinumab)

Recruiting
  • Myelodysplastic Syndromes
  • Duarte, California
  • +14 more
Jan 23, 2023

Primary Myelofibrosis, Myelofibrosis, PMF Trial (MBG453, NIS793, Spartalizumab)

Withdrawn
  • Primary Myelofibrosis
  • +4 more
  • (no location specified)
Mar 2, 2021

Metastatic Pancreatic Ductal Adenocarcinoma Trial in Worldwide (NIS793, Nab-paclitaxel, Gemcitabine)

Recruiting
  • Metastatic Pancreatic Ductal Adenocarcinoma
  • NIS793
  • +3 more
  • Fayetteville, Arkansas
  • +122 more
Jan 27, 2023

Myelofibrosis Trial in Worldwide (Ruxolitinib, Siremadlin, Crizanlizumab)

Suspended
  • Myelofibrosis
  • Adelaide, South Australia, Australia
  • +37 more
Aug 18, 2022

Diabetes, Diabetes, Type 2 Trial in Worldwide (Faster-acting insulin aspart, Insulin aspart, Insulin degludec)

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Faster-acting insulin aspart
  • +3 more
  • Concord, California
  • +166 more
Jan 6, 2022

Dermatitis, Dermatitis, Atopic, Eczema Trial in Worldwide (PF-04965842 100 mg, PF-04965842 200 mg, Placebo)

Completed
Has Results
  • Dermatitis
  • +9 more
  • PF-04965842 100 mg
  • +2 more
  • Birmingham, Alabama
  • +234 more
Sep 17, 2021

Neuromuscular Diseases Trial in Taipei (Neuromuscular ultrasound, Muscle MRI, Nerve conduction studies and autonomic function

Recruiting
  • Neuromuscular Diseases
  • Neuromuscular ultrasound
  • +11 more
  • Taipei, Taiwan
    National Taiwan Univeristy Hospital
Sep 9, 2021

Atrial Fibrillation Trial in Worldwide (Milvexian, Apixaban, Placebo)

Not yet recruiting
  • Atrial Fibrillation
  • Alexander City, Alabama
  • +1158 more
Feb 24, 2023

Cardiovascular Diseases, Statin Adverse Reaction Trial in Worldwide (Bempedoic acid 180 mg tablet, Matching tablet)

Active, not recruiting
  • Cardiovascular Diseases
  • Statin Adverse Reaction
  • Bempedoic acid 180 mg tablet
  • Matching placebo tablet
  • Birmingham, Alabama
  • +1359 more
Sep 7, 2021

Relapsing-remitting Multiple Sclerosis Trial in Worldwide (Evobrutinib, Placebo, Tecfidera)

Active, not recruiting
Has Results
  • Relapsing-remitting Multiple Sclerosis
  • Blagoevgrad, Bulgaria
  • +55 more
May 4, 2021

Anemia in Chronic Kidney Disease in Non-dialysis Patients Trial in Worldwide (Roxadustat, Darbepoetin alfa)

Completed
Has Results
  • Anemia in Chronic Kidney Disease in Non-dialysis Patients
  • Vienna, Austria
  • +124 more
Apr 19, 2021

Bronchiectasis Trial in Worldwide (280 mg Arikayce™, Matching Placebo for Cohort 1, 560 mg Arikayce™)

Completed
Has Results
  • Bronchiectasis
  • 280 mg Arikayce™
  • +3 more
  • Washington, District of Columbia
  • +17 more
Jun 20, 2019

Acute Heart Failure (AHF) Trial in Worldwide (Serelaxin, Standard of Care)

Terminated
Has Results
  • Acute Heart Failure (AHF)
  • Feldkirch, Austria
  • +357 more
Dec 18, 2018

Diabetes, Diabetes, Type 1 Trial in Worldwide (Faster-acting insulin aspart, insulin aspart, insulin degludec)

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 1
  • Faster-acting insulin aspart
  • +2 more
  • Phoenix, Arizona
  • +154 more
May 22, 2019

Atherosclerosis Trial in Worldwide (Canakinumab, Placebo, Standard of care)

Completed
Has Results
  • Atherosclerosis
  • Athens, Alabama
  • +1132 more
Jan 10, 2020

Relapsing-Remitting Multiple Sclerosis Trial in Worldwide (LY2127399, Placebo)

Completed
Has Results
  • Relapsing-Remitting Multiple Sclerosis
  • Phoenix, Arizona
  • +62 more
Nov 10, 2018

Relapsing Multiple Sclerosis Trial in Worldwide (peginterferon beta-1a)

Completed
Has Results
  • Relapsing Multiple Sclerosis
  • peginterferon beta-1a
  • Atlanta, Georgia
  • +150 more
Nov 17, 2016

Colitis, Ulcerative Trial in Worldwide (Placebo, Golimumab 50 mg, Golimumab 100 mg)

Completed
Has Results
  • Colitis, Ulcerative
  • Placebo
  • +3 more
  • Birmingham, Alabama
  • +308 more
Mar 24, 2016

Colitis, Ulcerative Trial in Worldwide (Placebo, Golimumab 100 mg, Golimumab 200 mg)

Completed
Has Results
  • Colitis, Ulcerative
  • Placebo
  • +4 more
  • Birmingham, Alabama
  • +207 more
Jan 14, 2014